Search research articles
Contact Us
Filters
Showing results (101-110 of 111) with videos related to
Page
of 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2005
Phase I pharmacokinetic and pharmacodynamic study of weekly 1-hour and 24-hour infusion BMS-214662, a farnesyltransferase inhibitor, in patients with advanced solid tumors
Josep Tabernero, Fredy Rojo, Irene Marimón, et al.
Nature Communications
|
January 6, 2025
MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial
Mrinal Gounder, Melissa Johnson, Rebecca S Heist, et al.
Cancers
|
January 11, 2024
The PedAL/EuPAL Project: A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia
Valeria Ceolin, Sae Ishimaru, Seth E Karol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2016
Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Arend von Stackelberg, Franco Locatelli, Gerhard Zugmaier, et al.
Chemistry & Biology
|
November 2, 2010
Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agents
Shudong Wang, Gary Griffiths, Carol A Midgley, et al.
Journal of Neurovirology
|
January 15, 2014
Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system
Cagla Akay, Michael Cooper, Akinleye Odeleye, et al.
Journal of Neurovirology
|
June 19, 2025
Correction to: Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system
Cagla Akay, Michael Cooper, Akinleye Odeleye, et al.
Cell
|
June 7, 2025
Microbiome mismatches from microbiota transplants lead to persistent off-target metabolic and immunomodulatory effects
Orlando DeLeon, Mora Mocanu, Alan Tan, et al.
Blood
|
October 7, 2020
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study
Eytan M Stein, Courtney D DiNardo, Amir T Fathi, et al.
Molecular Ecology
|
November 15, 2017
Biogeography of mutualistic fungi cultivated by leafcutter ants
Ulrich G Mueller, Heather D Ishak, Sofia M Bruschi, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 111) with videos related to
Sort By:
Page
of 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2005
Phase I pharmacokinetic and pharmacodynamic study of weekly 1-hour and 24-hour infusion BMS-214662, a farnesyltransferase inhibitor, in patients with advanced solid tumors
Josep Tabernero, Fredy Rojo, Irene Marimón, et al.
Nature Communications
|
January 6, 2025
MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial
Mrinal Gounder, Melissa Johnson, Rebecca S Heist, et al.
Cancers
|
January 11, 2024
The PedAL/EuPAL Project: A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia
Valeria Ceolin, Sae Ishimaru, Seth E Karol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2016
Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Arend von Stackelberg, Franco Locatelli, Gerhard Zugmaier, et al.
Chemistry & Biology
|
November 2, 2010
Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agents
Shudong Wang, Gary Griffiths, Carol A Midgley, et al.
Journal of Neurovirology
|
January 15, 2014
Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system
Cagla Akay, Michael Cooper, Akinleye Odeleye, et al.
Journal of Neurovirology
|
June 19, 2025
Correction to: Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system
Cagla Akay, Michael Cooper, Akinleye Odeleye, et al.
Cell
|
June 7, 2025
Microbiome mismatches from microbiota transplants lead to persistent off-target metabolic and immunomodulatory effects
Orlando DeLeon, Mora Mocanu, Alan Tan, et al.
Blood
|
October 7, 2020
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study
Eytan M Stein, Courtney D DiNardo, Amir T Fathi, et al.
Molecular Ecology
|
November 15, 2017
Biogeography of mutualistic fungi cultivated by leafcutter ants
Ulrich G Mueller, Heather D Ishak, Sofia M Bruschi, et al.
Page
of 12